Cidara
portfoliocompanies
company snapshot
Cidara Therapeutics (Nasdaq: CDTX) is applying its small molecule immunotherapy platform to treat life-threatening illnesses exacerbated by deficiencies of the human immune system. Cidara's initial focus is on devastating fungal infections that often complicate cancer and transplant treatments.
website
www.cidara.comLeadership
Follow The Company
FacebookTwitterLinkedInGoogle PlusRecent News1
FierceBiotech's 2014 Fierce 15
October, 2014